Titel

Merkliste
1 Ergebnisse

Summary of medicines and commodities available for lymphoed..:

John Chiphwanya ; Square Mkwanda ; Storn Kabuluzi...
https://figshare.com/articles/dataset/Summary_of_medicines_and_commodities_available_for_lymphoedema_at_the_56_facilities_surveyed_in_2019_/25236538. , 2024

Link: https://doi.org/10.1371/journal.pntd.0011957.t004

RT Journal
T1 <Title>Summary of medicines and commodities available for lymphoedema at the 56 facilities surveyed in 2019</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonianinsp:oai:figshare.com:article_25236538&Exemplar=1&LAN=DE
				
A1 John Chiphwanya
A1 Square Mkwanda
A1 Storn Kabuluzi
A1 Themba Mzilahowa
A1 Bagrey Ngwira
A1 Dorothy E. Matipula
A1 Limbikani Chaponda
A1 Paul Ndhlova
A1 Prince Katchika
A1 Chawananga Mahebere Chirambo
A1 Philemon Moses
A1 Justin Kumala
A1 Martin Chiumia
A1 Carrie Barrett
A1 Hannah Betts
A1 Joan Fahy
A1 Maria Rebollo Polo
A1 Lisa Reimer
A1 Michelle C. Stanton
A1 Brent Thomas
A1 Sian Freer
A1 David H. Molyneux
A1 Moses J. Bockarie
A1 Charles D. Mackenzie
A1 Mark J. Taylor
A1 Sarah Martindale
A1 Louise A. Kelly-Hope
YR 2024
K1 Medicine
K1 Biotechnology
K1 Cancer
K1 Infectious Diseases
K1 Virology
K1 Computational Biology
K1 standard sentinel site
K1 operational research initiatives
K1 obtained via house
K1 clinical case estimates
K1 causing severe pain
K1 access group surveys
K1 1 &# 8211
K1 world health organization
K1 routine health systems
K1 public health problem
K1 supported endemic countries
K1 mass drug administration
K1 malawi &# 8217
K1 parasitic disease transmitted
K1 painful disease caused
K1 transmission assessment surveys
K1 successfully eliminated lf
K1 past two decades
K1 efforts towards post
K1 disabling clinical conditions
K1 malawi </ p
K1 infected mosquitoes transmit
K1 high infection rates
K1 eliminate lymphatic filariasis
K1 gpelf recommended strategies
K1 lymphatic filariasis
K1 health personnel
K1 gpelf strategies
K1 endemic regions
K1 drug regime
K1 chronic conditions
K1 malawi previously
K1 disease across
K1 disabling disease
K1 xlink ">
K1 worked tirelessly
K1 total population
K1 term sustainability
K1 supplementary interventions
K1 spot check
K1 remarkable given
K1 remains vigilant
K1 receive validation
K1 programmatic barriers
JF https://figshare.com/articles/dataset/Summary_of_medicines_and_commodities_available_for_lymphoedema_at_the_56_facilities_surveyed_in_2019_/25236538
LK http://dx.doi.org/https://doi.org/10.1371/journal.pntd.0011957.t004
DO https://doi.org/10.1371/journal.pntd.0011957.t004
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)